Context Therapeutics updates corporate presentation for June 2025

Context Therapeutics Inc.

Company issued an updated corporate presentation dated June 2025.
Presentation emphasizes T cell engager platform for solid tumors.
Slide 17 of the presentation is incorporated by reference under Item 8.01.
No clinical data, financial results, or guidance were disclosed in the filing.

item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.